Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.
Sandström E, Nilsson C, Hejdeman B, Bråve A, Bratt G, Robb M, Cox J, Vancott T, Marovich M, Stout R, Aboud S, Bakari M, Pallangyo K, Ljungberg K, Moss B, Earl P, Michael N, Birx D, Mhalu F, Wahren B, Biberfeld G; HIV Immunogenicity Study 01/02 Team. Sandström E, et al. Among authors: bratt g. J Infect Dis. 2008 Nov 15;198(10):1482-90. doi: 10.1086/592507. J Infect Dis. 2008. PMID: 18808335 Free PMC article. Clinical Trial.
DNA mucosal HIV vaccine in humans.
Lundholm P, Leandersson AC, Christensson B, Bratt G, Sandström E, Wahren B. Lundholm P, et al. Among authors: bratt g. Virus Res. 2002 Jan 30;82(1-2):141-5. doi: 10.1016/s0168-1702(01)00396-3. Virus Res. 2002. PMID: 11885941 Review.
Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up.
Hejdeman B, Leandersson AC, Fredriksson EL, Sandström E, Wahren B, Bratt G. Hejdeman B, et al. Among authors: bratt g. HIV Med. 2003 Apr;4(2):101-10. doi: 10.1046/j.1468-1293.2003.00148.x. HIV Med. 2003. PMID: 12702130 Free article. Clinical Trial.
Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruption.
Matsuda R, Boström AC, Fredriksson M, Fredriksson EL, Bratt G, Hejdeman B, Sandström E, Okuda K, Wahren B. Matsuda R, et al. Among authors: bratt g. Microbiol Immunol. 2006;50(8):629-35. doi: 10.1111/j.1348-0421.2006.tb03838.x. Microbiol Immunol. 2006. PMID: 16924148 Free article.
156 results